Good Evening Market Enthusiast,
Most biotech stories die in the lab.
This one didn't.
FDA-approved product is live and shipping now. National distribution across every major wholesaler is locked in. The permanent reimbursement code is active. Physicians are already prescribing.
This isn't a "preparing to launch" story anymore. This is
execution. Real infrastructure. Real momentum.
The narrative changes tomorrow at 9:30am EST.
Don't miss what happens next.
Max Masters
Co-founder, Market Tips Newsletter